Physician profile
Robert M Currin
NPI 1992805402
$1,816.74
in general payments reported to CMS, 2019-2025
16 companies · $264 in 2025
The $264 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $378 · 2020: $19.40 · 2021: $78.34 · 2022: $132 · 2023: $260 · 2024: $684 · 2025: $264.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,127 · Entertainment: $81.58.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,127.36 |
| Entertainment | $81.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopervision INC. | $554.35 | 2021-2025 | Myday Contact Lens, Misight Contact Lens, Clariti Contact Lens |
| Alcon Vision LLC | $287.31 | 2023-2025 | Total30, Hydrus Microstent, Precision 1 |
| Biotissue Holdings INC. | $135.49 | 2019-2024 | |
| Aerie Pharmaceuticals, INC. | $122.03 | 2019 | |
| Lkc Technologies, INC. | $112.25 | 2024 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $99.99 | 2019 | |
| Allergan, INC. | $91.34 | 2019 | |
| Optos, INC. | $81.58 | 2024 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Sun Pharmaceutical Industries INC. | $67.53 | 2023 | Cequa |
| Abbvie INC. | $62.40 | 2025 | |
| Topcon Healthcare, INC. | $58.85 | 2024 | |
| Visioneering Technologies, INC. | $40.35 | 2019 | |
| Bausch & Lomb Americas INC. | $33.31 | 2022-2025 | Miebo, Xiidra |
| Novartis Pharmaceuticals Corporation | $25.52 | 2019-2023 | |
| Tarsus Pharmaceuticals, INC. | $25.04 | 2024 | Xdemvy |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Carl Zeiss Meditec Ag | $19.40 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Currin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.